newsfilter
← Latest News
GlobeNewswire·

HilleVax to Participate in Fireside Chat at the SVB Securities Virtual Vaccine Forum

BOSTON, Aug. 15, 2022 (GLOBE NEWSWIRE) -- HilleVax, Inc. (NASDAQ:HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that it will participate in a fireside chat during the SVB Secu